Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Foresite Capital Management V, LLC (CIK 1792206) reported $271.0M across 8 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: ALMS ($129.9M, 47.94%), CGON ($68.0M, 25.08%), IRON ($23.9M, 8.83%), HIMS ($15.3M, 5.65%), ($14.0M, 5.15%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ALMS | ALUMIS INC. | $129.9M | 47.94% | 5.9M | Added |
| 2 | CGON | CG Oncology, Inc. | $68.0M | 25.08% | 1.0M | Hold |
| 3 | IRON | Disc Medicine, Inc. | $23.9M | 8.83% | 374,069 | Added |
| 4 | HIMS | Hims & Hers Health, Inc. | $15.3M | 5.65% | 738,151 | Added |
| 5 | Eikon Therapeutics, Inc. | $14.0M | 5.15% | 1.3M | New | |
| 6 | LYEL | Lyell Immunopharma, Inc. | $9.6M | 3.53% | 477,078 | Hold |
| 7 | PHVS | Pharvaris N.V. | $5.5M | 2.02% | 194,125 | New |
| 8 | NRIX | Nurix Therapeutics, Inc. | $4.1M | 1.52% | 265,000 | New |
| 9 | MAZE | Maze Therapeutics, Inc. | $773,264 | 0.29% | 25,905 | Trimmed |
| 10 | NTRA | Natera, Inc. | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-03-31